LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Long noncoding RNAs (lncRNAs), widely expressed in mammalian cells, play pivotal roles in osteosarcoma (OS) progression. Nevertheless, the detailed molecular mechanisms of lncRNA KIAA0087 in OS remain obscure. Here, the roles of KIAA0087 in OS tumorigenesis were investigated. KIAA0087 and miR-411-3p levels were detected by RT-qPCR. Malignant properties were assessed by CCK-8, colony formation, flow cytometry, wound healing, and transwell assays. SOCS1, EMT, and JAK2/STAT3 pathway-related protein levels were measured by western blotting. Direct binding between miR-411-3p and KIAA0087/SOCS1 was validated by a dual-luciferase reporter, RIP, and FISH assays. In vivo growth and lung metastasis were evaluated in nude mice. The expression levels of SOCS1, Ki-67, E-cadherin, and N-cadherin in tumor tissues were measured by immunohistochemical staining. Downregulation of KIAA0087 and SOCS1 and upregulation of miR-411-3p were found in OS tissues and cells. Low expression of KIAA0087 was associated with a poor survival rate. Forced expression of KIAA0087 or miR-411-3p inhibition repressed the growth, migration, invasion, EMT, and activation of the JAK2/STAT3 pathway and triggered apoptosis of OS cells. However, the opposite results were found with KIAA0087 knockdown or miR-411-3p overexpression. Mechanistic experiments indicated that KIAA0087 enhanced SOCS1 expression to inactivate the JAK2/STAT3 pathway by sponging miR-411-3p. Rescue experiments revealed that the antitumor effects of KIAA0087 overexpression or miR-411-3p suppression were counteracted by miR-411-3p mimics or SOCS1 inhibition, respectively. Finally, in vivo tumor growth and lung metastasis were inhibited in KIAA0087-overexpressing or miR-411-3p-inhibited OS cells. In summary, the downregulation of KIAA0087 promotes the growth, metastasis, and EMT of OS by targeting the miR-411-3p-mediated SOCS1/JAK2/STAT3 pathway.
Abstract
Long noncoding RNAs (lncRNAs), widely expressed in mammalian cells, play pivotal roles in osteosarcoma (OS) progression. Nevertheless, the detailed molecular mechanisms of lncRNA KIAA0087 in OS remain obscure. Here, the roles of KIAA0087 in OS tumorigenesis were investigated. KIAA0087 and miR-411-3p levels were detected by RT-qPCR. Malignant properties were assessed by CCK-8, colony formation, flow cytometry, wound healing, and transwell assays. SOCS1, EMT, and JAK2/STAT3 pathway-related protein levels were measured by western blotting. Direct binding between miR-411-3p and KIAA0087/SOCS1 was validated by a dual-luciferase reporter, RIP, and FISH assays. In vivo growth and lung metastasis were evaluated in nude mice. The expression levels of SOCS1, Ki-67, E-cadherin, and N-cadherin in tumor tissues were measured by immunohistochemical staining. Downregulation of KIAA0087 and SOCS1 and upregulation of miR-411-3p were found in OS tissues and cells. Low expression of KIAA0087 was associated with a poor survival rate. Forced expression of KIAA0087 or miR-411-3p inhibition repressed the growth, migration, invasion, EMT, and activation of the JAK2/STAT3 pathway and triggered apoptosis of OS cells. However, the opposite results were found with KIAA0087 knockdown or miR-411-3p overexpression. Mechanistic experiments indicated that KIAA0087 enhanced SOCS1 expression to inactivate the JAK2/STAT3 pathway by sponging miR-411-3p. Rescue experiments revealed that the antitumor effects of KIAA0087 overexpression or miR-411-3p suppression were counteracted by miR-411-3p mimics or SOCS1 inhibition, respectively. Finally, in vivo tumor growth and lung metastasis were inhibited in KIAA0087-overexpressing or miR-411-3p-inhibited OS cells. In summary, the downregulation of KIAA0087 promotes the growth, metastasis, and EMT of OS by targeting the miR-411-3p-mediated SOCS1/JAK2/STAT3 pathway.
참고문헌 (33)
- Caudill, J. S., "Diagnosis and management of bone malignancy in adolescence", Adolesc. Med. State Art. Rev, 18, pp.62~78 (2007)
- Ottaviani, G., "The epidemiology of osteosarcoma", Cancer Treat. Res, 152, pp.3~13 (2009)
- Tsukamoto, S., "Current treatment considerations for osteosarcoma metastatic at presentation", Orthopedics, 43, pp.e345~e358 (2020)
- Qiu, S., "Marital status and survival in osteosarcoma patients : an analysis of the surveillance, epidemiology, and end results(SEER)database", Med. Sci. Monit, 25, pp.8190~8203 (2019)
- Lu, K. H., "Molecular and cellular mechanisms of melatonin in osteosarcoma", Cells, 8, pp.1618~ (2019)
- Singh, S., "Consequences of EMT-driven changes in the immune microenvironment of breast cancer and therapeutic response of cancer cells", J. Clin. Med, 8, pp.642~ (2019)
- Xing, S., "Down-regulation of PDGFRbeta suppresses invasion and migration in osteosarcoma cells by influencing epithelial-mesenchymal transition", FEBS Open Bio, 10, pp.1748~1757 (2020)
- Zheng, H. L., "Characterization of LncRNA SNHG22 as a protector of NKIRAS2through miR-4492 binding in osteosarcoma", Aging(Albany NY), 12, pp.18571~18587 (2020)
- Xu, J., "Distinct expression profile of lncRNA in endometrial carcinoma", Oncol. Rep, 36, pp.3405~3412 (2016)
- Militello, G., "Screening and validation of lncRNAs and circRNAs as miRNA sponges", Brief Bioinform, 18, pp.780~788 (2017)
- Garzon, R., "MicroRNAs in cancer", Annu. Rev. Med, 60, pp.167~179 (2009)
- Yi, X., "MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma", J. Orthop. Surg. Res, 15, pp.454~ (2020)
- Gourbault, O., "MicroRNAs as biomarkers in canine osteosarcoma: a new future?", Vet. Sci, 7, pp.146~ (2020)
- Liu, J., "The role of significantly deregulated MicroRNAs in osteosarcoma based on bioinformatic analysis", Technol. Health Care, 29, pp.333~341 (2020)
- Beaurivage, C., "SOCS1 in cancer : an oncogene and a tumor suppressor", Cytokine, 82, pp.87~94 (2016)
- Zhang, X. H., "Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia", Oncol. Rep, 40, pp.1008~1016 (2018)
- Hashimoto, M., "Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation", Cancer Sci, 100, pp.730~736 (2009)
- Gong, H. L., "MicroRNA-29a suppresses the invasion and migration of osteosarcoma cells by regulating the SOCS1", NF-kappaB signalling pathway through negatively targeting DNMT3B, 2019, pp.44, 1219~1232
- Bielack, S. S., "Prognostic factors in high-grade osteosarcoma of the extremities or trunk : an analysis of 1, 702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols", J. Clin. Oncol, 20, pp.776~790 (2002)
- Wang, H., "Knockdown of long noncoding RNA TUG1inhibits the proliferation and cellular invasion of osteosarcoma cells by sponging miR-153", Oncol. Res, 26, pp.665~673 (2018)
- Han, F., "Long noncoding RNA ATB promotes osteosarcoma cell proliferation, migration and invasion by suppressing miR-200s", Am. J. Cancer Res, 7, pp.770~783 (2017)
- Li, R., "LINC01116 promotes doxorubicin resistance in osteosarcoma by epigenetically silencing miR-424-5p and inducing epithelial-mesenchymal transition", Front. Pharmacol, 12, pp.632206~ (2021)
- Zeng, S. X., "High expression of TRIM29(ATDC)contributes to poor prognosis and tumor metastasis by inducing epithelialmesenchymal transition in osteosarcoma", Oncol. Rep, 38, pp.1645~1654 (2017)
- Shao, S., "Tspan9 induces EMT and promotes osteosarcoma metastasis via activating FAK-Ras-ERK1", 2 pathway, 2022, pp.12, 774988~
- Fu, S. W., "LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p", NFAT5 axis, 2020, pp.20, 415~
- Zeng, Y. T., "REX1 promotes EMT-induced cell metastasis by activating the JAK2", STAT3-signaling pathway by targeting SOCS1in cervical cancer, 2019, pp.38, 6940~6957
- David, M., "Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells", Mol. Oncol, 8, pp.942~955 (2014)
- Groner, B., "Jak Stat signaling and cancer : opportunities, benefits and side effects of targeted inhibition", Mol. Cell. Endocrinol, 451, pp.1~14 (2017)
- Li, S., "RUNX3 protects against acute lung injury by inhibiting the JAK2", STAT3pathway in rats with severe acute pancreatitis, 2019, pp.23, 5382~5391
- Chen, J., "Downregulation of miR-19a inhibits the proliferation and promotes the apoptosis of osteosarcoma cells by regulating the JAK2", STAT3pathway, 2020, pp.20, 173~
- Ge, X., "Exosomal transfer of LCP1 PRomotes Osteosarcoma Cell Tumorigenesis and Metastasis by Activating the JAK2", STAT3 signaling pathway, 2020, pp.21, 900~915
- Huang, H., "ML264 inhibits osteosarcoma growth and metastasis via inhibition of JAK2", STAT3 and WNT, J. Cell. Mol. Med, pp.2020, 24[DOI]
- Cui, Y., "STAT3 regulates hypoxia-induced epithelial mesenchymal transition in oesophageal squamous cell cancer", Oncol. Rep, 36, pp.108~116 (2016)